Tag: TRV027

Researchers to test potential COVID-19 treatment in UK

by Selina McKee | Jun 15, 2020 | News | 0

TRV027 targets cell pathways thought to be major drivers of severe illness in COVID-19

Read More

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999